These results align with findings from previous NMAs, ITCs and the head-to-head SURMOUNT-5 trial, where the NMA results support the relative strength of tirzepatide compared to liraglutide and semaglutide in achieving weight reduction and reducing cardiometabolic risk factors among patients with obesity or overweight
Any neck symptoms require prompt medical attention, including a palpable lump, persistent hoarseness, difficulty swallowing, or unexplained shortness of breath
Yes, dry mouth is one of the most commonly reported oral side effects of GLP-1 medications
Abstract Glucagon-like peptide-1 (GLP-1) receptor agonists, widely prescribed for type 2 diabetes and weight management, are known for their metabolic benefits but may have unrecognized side effects
Appetite loss, headaches, and fatigue are also reported
If you normally inject on Wednesdays at 8 AM Eastern, inject at whatever time is 8 AM Eastern in your new location